Navigation Links
YM BIOSCIENCES REPORTS THIRD QUARTER 2009 OPERATIONAL AND FINANCIAL RESULTS
Date:5/14/2009

1,777,864 4,832,619 5,478,264 Expenses: General and adminis- trative 1,190,039 1,416,872 3,530,626 5,526,388 Licensing and product development 3,259,177 4,286,792 11,525,789 12,052,278 ------------------------------------------------------------------------- 4,449,216 5,703,664 15,056,415 17,578,666 ------------------------------------------------------------------------- Loss before the undernoted (3,471,454) (3,925,800) (10,223,796) (12,100,402) Gain on foreign exchange 51,122 15,584 143,009 29,716 Gain (loss) on short- term deposits (54,507) 91,569 (31,789) 217,985 Loss on disposal of property and equipment - - - (70,143) Other income - - 307,140 - ------------------------------------------------------------------------- Loss and comprehensive loss for the period $ (3,474,839) $ (3,818,647) $ (9,805,436) $ (11,922,844) ------------------------------------------------------------------------- ------------------------------------------------------------------------- Basic and diluted loss per common share $ (0.06) $ (0.07) $ (0.18) $ (0.21) ------------------------------------------------------------------------- ------------------------------------------------------------------------- Weighted average number of common shares outstanding 55,835,356 55,835,356 55,835,356 55,835,356 ------------------------------------------------------------------------- -----------------------------------------------------
'/>"/>
SOURCE YM BioSciences Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Frost & Sullivan Awards Precision Biosciences for Technology Innovation and Molecular Design Process in the Genomics Market
2. Neurocrine Biosciences to Present at the Deutsche Bank 34th Annual Health Care Conference
3. MichBio Leader Cites New Senate Biosciences Task Force and House Subcommittee as Evidence of States Growing Awareness of Industrys Economic Importance
4. Neurocrine Biosciences Reports First Quarter 2009 Results
5. Sangamo BioSciences Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research
6. Sangamo BioSciences Announces Publication in Nature of the Use of Zinc Finger Nucleases to Accelerate Precision Trait Stacking in Commercial Crop Species
7. ImQuest BioSciences and Arisyn Therapeutics Announce Strategic Partnership to Develop Infectious Disease and Cancer Drugs
8. LaVoie Group Selected by Vaccine Developer, Profectus BioSciences, as Agency of Record
9. Former GE Healthcare Director, Per Foss Appointed CEO for HUNT Biosciences
10. Sangamo BioSciences Announces First Quarter 2009 Conference Call and Webcast
11. Cell Biosciences Launches Next-Generation Protein Characterization System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... Already well respected for accuracy, HEIDENHAIN now ... Length Gauge offerings with new variants of its successful ... HEIDENHAIN’s pencil probe-style SPECTO length gauge series now offers ... 1Vpp, 12mm stroke length variants of the SPECTO series ... variant with a weak spring, 0.4N of gauging force, ...
(Date:2/26/2015)... 2015  Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), ... technologies are used to develop, manufacture and sell ... chemical, biopharmaceutical and industrial enzyme industries, announced today ... year ending December 31, 2014 after market close ... a conference call that day at 5:00 p.m. ...
(Date:2/26/2015)... Feb. 26, 2015  Epic Sciences announced today that ... present at the 35th Annual Cowen and Company Health ... the MIT Room, 3rd Floor. The conference will be ... Mass. Epic is developing diagnostic tests of ... and proteomic changes that occur during the course of ...
(Date:2/26/2015)... (PRWEB) February 26, 2015 On Wednesday, ... to building a nationwide Clostridium difficile (C. diff) awareness ... diff burden study by the Centers for Disease Control ... caused almost half a million infections among Americans in ... nursing homes. , The study also estimates that ...
Breaking Biology Technology:Accuracy and Versatile Gauging Go Hand in Hand at HEIDENHAIN 2Dyadic International To Announce Fourth Quarter 2014 Financial Results And Host Conference Call On Wednesday, March 11, 2015 2Dyadic International To Announce Fourth Quarter 2014 Financial Results And Host Conference Call On Wednesday, March 11, 2015 3Epic Sciences to Present at 35th Annual Cowen and Company Health Care Conference 2Peggy Lillis Foundation Lauds CDC's New, More Comprehensive Study on the Burden of C. difficile Infections in the United States 2Peggy Lillis Foundation Lauds CDC's New, More Comprehensive Study on the Burden of C. difficile Infections in the United States 3Peggy Lillis Foundation Lauds CDC's New, More Comprehensive Study on the Burden of C. difficile Infections in the United States 4
... Wisconsin has some catching up to do even among ... investment, according to the latest Midwest Health Care Venture ... publicly disclosed investments in 12 states or regions in ... than three times the investment Wisconsin had. , ,These ...
... we continue to review biotech results for 2005 and try to ... , ,Another research tool I have always found useful for this ... the biotech industry. One of the things I like about Burrill ... the biotech industry's biggest cheerleaders. , ,Another aspect is that he ...
... The University of Wisconsin-Madison MBA program was ... and 19th among U.S. public university programs by the ... list in 2005. , ,These rankings are based on ... Financial Times compiled data provided by the schools and ...
Cached Biology Technology:2005 was a tough year for U.S. biotech financing 22005 was a tough year for U.S. biotech financing 32005 was a tough year for U.S. biotech financing 42005 was a tough year for U.S. biotech financing 5
(Date:1/22/2015)... Valid S.A. ("Company") (BM&FBOVESPA: VLID3 ON), is pleased to inform ... State of Washington,s Department of Licensing, in the ... issuance system for driver,s licenses and identification cards to its ... development will start in January 2015, with enrollment and card ...
(Date:1/22/2015)...  A man-made form of insulin delivered by nasal spray ... adults with mild cognitive impairment and Alzheimer,s disease dementia, ... Wake Forest Baptist Medical Center. The study,s ... impairment (MCI) or mild to moderate Alzheimer,s dementia (AD). ...
(Date:1/22/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/wxdglm/global_wearable ... "Global Wearable Technologies Market and Applications, Opportunities, Industry ... Forecast 2014-2020" report to their offering. ... that can be worn on the user,s body ...
Breaking Biology News(10 mins):Valid USA Signs Contract For Washington Driver's License Issuance 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3Global Wearable Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, Size, Growth, Share, Overview, Trends and Forecast 2014-2020 2
... A unique rover-based life detection system developed by Carnegie ... Chile's Atacama Desert, according to results being presented at ... in Houston. This marks the first time a rover-based ... this harsh region, which serves as a test bed ...
... chemical sensors that can be placed in the bloodstream ... (pH), or glucose levels is a major challenge for ... body responds to these foreign objects in ways that ... In the bloodstream, clots form on the surface of ...
... process by which a single gene can initiate production ... said Baylor College of Medicine researchers in a report ... Cell. "A major question in biology today is how ... proteins," said Dr. Bert O'Malley, chair of the BCM ...
Cached Biology News:Robot-based system developed at Carnegie Mellon detects life in Chile's Atacama desert 2Robot-based system developed at Carnegie Mellon detects life in Chile's Atacama desert 3Robot-based system developed at Carnegie Mellon detects life in Chile's Atacama desert 4Polymers with copper show promise for implanted sensors 2Polymers with copper show promise for implanted sensors 3Controlling protein diversity 2
Mouse anti human pro-Relaxin-2...
Rabbit polyclonal to Dishevelled 2 ( Abpromise for all tested applications). entrezGeneID: 1856 SwissProtID: O14641...
... to ErbB 2 - BSA and ... all tested applications). ... to KLH, corresponding to C terminal ... Entrez GeneID: ...
Anti human PPAR gamma2 mouse monoclonal antibody...
Biology Products: